1. Huang, Runzhi, Sun, Hanlin, Lin, Ruoyi, Meng, Tong, Huang, Zongqiang. 2022. The role of tetraspanins pan-cancer. In iScience, 25, 104777. doi:10.1016/j.isci.2022.104777. https://pubmed.ncbi.nlm.nih.gov/35992081/
2. Zhou, Cefan, Liang, Yanyan, Zhou, Li, Chen, Xing-Zhen, Tang, Jingfeng. 2020. TSPAN1 promotes autophagy flux and mediates cooperation between WNT-CTNNB1 signaling and autophagy via the MIR454-FAM83A-TSPAN1 axis in pancreatic cancer. In Autophagy, 17, 3175-3195. doi:10.1080/15548627.2020.1826689. https://pubmed.ncbi.nlm.nih.gov/32972302/
3. Ou, Yiyan, Chen, Ruiling, Qian, Qiwei, Ma, Xiong, Wang, Qixia. 2022. The immunological characteristics of TSPAN1 expressing B cells in autoimmune hepatitis. In Frontiers in immunology, 13, 1076594. doi:10.3389/fimmu.2022.1076594. https://pubmed.ncbi.nlm.nih.gov/36591302/
4. Han, Jihua, Xie, Changming, Liu, Bo, Zhang, Jiewu, Nie, Chunlei. 2023. Tetraspanin 1 regulates papillary thyroid tumor growth and metastasis through c-Myc-mediated glycolysis. In Cancer science, 114, 4535-4547. doi:10.1111/cas.15970. https://pubmed.ncbi.nlm.nih.gov/37750019/
5. Lu, Zhengmao, Luo, Tianhang, Nie, Mingming, Fang, Guoen, Xue, Xuchao. 2015. TSPAN1 functions as an oncogene in gastric cancer and is downregulated by miR-573. In FEBS letters, 589, 1988-94. doi:10.1016/j.febslet.2015.05.044. https://pubmed.ncbi.nlm.nih.gov/26054975/
6. Wang, Ming-Dian, Li, Hui-Ting, Peng, Li-Xia, Cao, Yun, Qian, Chao-Nan. 2023. TSPAN1 inhibits metastasis of nasopharyngeal carcinoma via suppressing NF-kB signaling. In Cancer gene therapy, 31, 454-463. doi:10.1038/s41417-023-00716-w. https://pubmed.ncbi.nlm.nih.gov/38135697/
7. Zhang, Xiaobo, Shi, Gang, Gao, Feng, Wang, Huaitao, Tan, Xiaodong. 2019. TSPAN1 upregulates MMP2 to promote pancreatic cancer cell migration and invasion via PLCγ. In Oncology reports, 41, 2117-2125. doi:10.3892/or.2019.6989. https://pubmed.ncbi.nlm.nih.gov/30720116/
8. Liu, Xiangjuan, Zhang, Jiahong, Zhao, Jun, Cheng, Yan, Jiang, Dandan. 2024. TSPAN1 overexpression as an indicator of poor prognosis in estrogen receptor-positive breast cancer. In Translational cancer research, 13, 4159-4171. doi:10.21037/tcr-24-409. https://pubmed.ncbi.nlm.nih.gov/39262478/
智鼠故事 
